Lori Laffel
Pediatric Endocrinology · Boston, MANPI 1275570228
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.2%. Among pediatric endocrinology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 268 payments — averaging $1063.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$60K
- Boehringer Ingelheim International GmbH$44K
- Dexcom, Inc.$28K
- Janssen Research & Development, LLC$26K
- Boehringer Ingelheim$26K
- Roche Diabetes Care GmbH$19K
- plus $81K from 15 others
Across 542 payments — averaging $5477.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Insulet Corporation$1.4M
- Dexcom, Inc.$673K
- Tandem Diabetes Care, Inc.$174K
- Sequel Med Tech, LLC$160K
- Mannkind Corporation$160K
- Eli Lilly$159K
- plus $222K from 5 others
What the payments were for
- Consulting fees$144,29151%
- Speaking & faculty fees$53,93119%
- Travel & lodging$80,42928%
- Food & beverage$6,3232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 83 | $60,496 |
| Boehringer Ingelheim International GmbH | 33 | $44,449 |
| Dexcom, Inc. | 9 | $28,102 |
| Janssen Research & Development, LLC | 8 | $26,400 |
| Boehringer Ingelheim | 56 | $26,016 |
| Roche Diabetes Care GmbH | 6 | $18,759 |
| Roche Diagnostics International Ltd | 2 | $16,324 |
| Sanofi-aventis U.S. LLC | 13 | $15,489 |
| Eli Lilly | 10 | $10,675 |
| Vertex | 11 | $7,395 |
| Novo Nordisk | 8 | $6,879 |
| Tandem Diabetes Care, Inc. | 7 | $4,421 |
| Insulet Corporation | 5 | $4,075 |
| Lexicon Pharmaceuticals, Inc. | 1 | $3,440 |
| Mannkind Corporation | 10 | $3,022 |
| Roche Diabetes Care, Inc. | 1 | $2,900 |
| Novo Nordisk AS | 1 | $2,400 |
| Dompe US, Inc. | 1 | $1,800 |
| Convatec Inc. | 1 | $1,600 |
| Abbott | 1 | $291 |
| Lifescan, Inc. | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$46,156
- INVOKANA$26,400
- DEXCOM G6 TRANSMITTER$19,846
- Accu-Chek Inform II Instrument with RF card$15,255
- TZIELD$9,521
- Tresiba$6,853
- NO PRODUCT DISCUSSED$5,809
- DEXCOM G7 GSS (161)$5,563
- t:slim X2 Insulin Pump with Control-IQ$4,264
- DC ACCU-CHEK Diabetes Management Solutions, Cables, Software, Kits and Accessori$4,184
- Omnipod$4,041
- AFREZZA$2,550
- DEXCOM CGM$2,500
- Accu-Chek Instruments$2,220
- MINIMED 780G$2,188
- Ladarixin$1,800
- AQUACEL AG$1,600
- SIMPLERA SENSOR$1,600
- HUMALOG$1,402
- Minimed 670G System$905
How this compares
$284,975 in reported general payments places this provider in the 95th percentile of 64 pediatric endocrinology providers in Massachusetts.
See all pediatric endocrinology providers in Massachusetts →
Other pediatric endocrinology in Boston
- Joseph WolfsdorfBoston$51K
- Lynne LevitskyBoston$22K
- Amy SeagrovesBoston$10K
- Katharine GarveyBoston$9K
- Carmen Soto RiveraBoston$6K
- Sonali MalhotraBoston$6K
- Madhusmita MisraBoston$4K
- Margaret Stefater-RichardsBoston$3K
- Alyssa HalperBoston$3K
- Maryanne QuinnBoston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.